$SLN News

HC Wainwright & Co. Downgrades Silence Therapeutics to Neutral, Lowers Price Target to $20

Does Silence Therapeutics (SLN) Have the Potential to Rally 82.84% as Wall Street Analysts Expect?

Nasdaq Jumps Over 1% As Tech Stocks Gain: Investor Sentiment Improves, Greed Index Remains In ‘Extreme Fear’ Zone

Is Silence Therapeutics (NasdaqGM:SLN) Reasonable Near Its $20 Deal Price?

Silence Therapeutics (SLN) Gets 130% Premium Offer From Merck, Shares Surge Over 100%

Silence Therapeutics: Downgrade To Hold On Merck KGaA Acquisition And PV siRNA

Merck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125%

Silence Therapeutics jumps 59% on Merck takeover

Silence Therapeutics stock soars 125% on Merck acquisition

Why Is Silence Therapeutics Stock Skyrocketing Monday?

Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany

Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday

Merck KGaA Agrees To Acquire Silence Therapeutics For $20 Per ADS In Cash

Silence Therapeutics (SLN) Loses 28.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Silence Therapeutics (SLN) Upgraded to Buy: Here's Why

Silence Therapeutics plc (SLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Silence Therapeutics to Participate in Three September Investor Conferences

Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering